KFA Private Wealth Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$378K Sell
2,598
-59
-2% -$8.15K 0.09% 100
2026
Q2
$342K Sell
2,657
-118
-4% -$13.8K 0.08% 106
2026
Q1
$334K Sell
2,775
-121
-4% -$14K 0.08% 121
2025
Q4
$305K Buy
2,896
+11
+0.4% +$1.03K 0.07% 119
2025
Q3
$242K Buy
2,885
+203
+8% +$16.7K 0.07% 125
2025
Q2
$212K Buy
+2,682
New +$213K 0.07% 129
2024
Q4
– Sell
-1,790
Closed -$203K – 92
2024
Q3
$203K Buy
+1,790
New +$213K 0.1% 80

Other funds holding MRK

KFA Private Wealth Group's MRK Position: Q3 2026 in Review

KFA Private Wealth Group reduced its Merck (MRK) stake by 2.2% in Q3 2026, selling an estimated $8.15K and leaving 2,598 shares worth $378K. The position accounts for 0.09% of the portfolio, ranked #100.

KFA Private Wealth Group first reported a position in MRK in Q3 2024 and has held it in 7 quarters since. 2,434 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • KFA Private Wealth Group held 2,598 shares of Merck worth $378K as of Q3 2026.
  • KFA Private Wealth Group sold 59 Merck shares in Q3 2026, an estimated $8.15K.
  • Merck made up 0.09% of KFA Private Wealth Group's portfolio in Q3 2026, its #100 holding.
  • KFA Private Wealth Group first reported a position in Merck in Q3 2024 and has held it in 7 quarters since.
  • 2,434 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on KFA Private Wealth Group's 13F filing for Q3 2026, filed 7 Oct 2026.